Scott Moorefield
Keine laufenden Positionen mehr
Profil
Scott Moorefield served as the Senior Vice President of Business Development at Silverback Therapeutics, Inc. and as the Chief Business Officer at Boundless Bio, Inc. from 2019 to 2020.
He holds a doctorate degree from North Carolina State University, which he received in 2005, and an undergraduate degree from The University of North Carolina at Chapel Hill, which he received in 1996.
Ehemalige bekannte Positionen von Scott Moorefield
| Unternehmen | Position | Ende |
|---|---|---|
| ARS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.03.2022 |
| BOUNDLESS BIO, INC. | Corporate Officer/Principal | 01.06.2020 |
Ausbildung von Scott Moorefield
| The University of North Carolina at Chapel Hill | Undergraduate Degree |
| North Carolina State University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BOUNDLESS BIO, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Silverback Therapeutics, Inc.
 Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Silverback Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. The company was founded by Peter A. Thompson January 4, 2016 and is headquartered in Seattle, WA. | Health Technology |
